Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
58.09
Dollar change
+1.78
Percentage change
3.16
%
CategoryEquity - Leveraged / Inverse Asset TypeEquities (Stocks) TagsU.S. Return% 1Y8.95% Shs Outstand Perf Week2.45%
SponsorProShares ETF Type Tagsequity Return% 3Y-11.07% Total Holdings230 Perf Month-6.70%
Fund Family Bond Type Tagsbiotechnology Return% 5Y1.59% AUM94.25M Perf Quarter3.01%
IndexNasdaq Biotech Index Average Maturity Tagspharmaceutical Return% 10Y NAV% Perf Half Y20.17%
Index Weighting Commodity Type Tagsleverage Return% SI NAV/sh Perf Year11.39%
Active/Passive Quant Type Tags- Flows% 1M0.11% 52W Range40.10 - 62.45 Perf YTD1.82%
Dividend TTM0.08 (0.14%) ESG Type Tags- Flows% 3M6.74% 52W High-6.98% Beta1.39
Dividend Ex-DateDec 20, 2023 Dividend Type Sector/Theme Flows% YTD6.74% 52W Low44.86% ATR (14)1.58
Expense0.95% Structure Type Region Flows% 1Y RSI (14)53.34 Volatility2.18% 2.80%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume5.66 Prev Close56.31
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume43.19K Price58.09
SMA200.97% SMA500.66% SMA20011.45% Trades Volume230,604 Change3.16%
Jan-31-22 01:15AM
Apr-08-21 07:30PM
Jan-28-21 04:55PM
Jun-22-20 01:00PM
May-07-20 03:28PM
10:12AM Loading…
Mar-15-20 10:12AM
Mar-12-20 01:22PM
Jan-03-20 10:44AM
May-07-19 04:57PM
Apr-24-19 04:04PM
Mar-05-19 03:32PM
Dec-11-18 03:32PM
Oct-29-18 09:15AM
Oct-19-18 03:47PM
Jun-15-18 05:06PM
11:07AM Loading…
Jan-10-18 11:07AM
Dec-04-17 04:42PM
Sep-15-17 03:26PM
Sep-08-17 10:31AM
Aug-31-17 01:39PM
Aug-30-17 10:53AM
Aug-25-17 07:37AM
Mar-15-17 08:26AM
Jan-30-17 10:24AM
Jan-18-17 06:00AM
Jan-06-17 11:37AM
Jan-04-17 12:25PM
Dec-21-16 10:35AM
Dec-19-16 11:29AM
Dec-09-16 04:14PM
04:53PM Loading…
Nov-18-16 04:53PM
Nov-11-16 05:58PM
Oct-28-16 11:37AM
Oct-17-16 12:40PM
10:32AM
Oct-14-16 03:06PM
Oct-12-16 09:24AM
Oct-11-16 01:03PM
Oct-10-16 12:30PM
Oct-03-16 05:04PM
05:04PM
Sep-26-16 11:12AM
11:12AM
Sep-20-16 02:04PM
12:04PM
Sep-19-16 09:30AM
09:30AM
Sep-12-16 11:05AM
09:31AM
09:31AM
Sep-06-16 10:26AM
Sep-01-16 08:06AM
Aug-29-16 03:32PM
Aug-25-16 10:08AM
Aug-22-16 11:39AM
Aug-15-16 08:29AM
Aug-08-16 02:16PM
Aug-05-16 07:14AM
07:13AM
Aug-04-16 07:15AM
Jul-26-16 12:35PM
09:08AM
Jul-25-16 09:38AM
Jul-21-16 02:06AM
Jul-04-16 11:54AM
Jun-27-16 12:18PM
Jun-02-16 11:49AM
May-31-16 10:41AM
03:28AM
May-25-16 12:17PM
May-17-16 10:06AM
May-05-16 10:59AM
May-04-16 09:21PM
May-03-16 11:59AM
May-02-16 12:01PM
Apr-28-16 01:22PM
Apr-22-16 08:24AM
Apr-19-16 08:15AM
Apr-18-16 11:05AM
Apr-13-16 09:07AM
Apr-08-16 09:08AM
Apr-04-16 10:14AM
Apr-01-16 12:57PM
Mar-31-16 09:56AM
Mar-24-16 11:04AM
Mar-07-16 10:59AM
Mar-01-16 10:44AM
Feb-29-16 09:43PM
Feb-05-16 07:21AM
Jan-31-16 02:46PM
Jan-14-16 10:55AM
Jan-06-16 08:30AM
Dec-22-15 12:56PM
Dec-16-15 02:52PM
Oct-13-15 09:30AM
Oct-05-15 11:45AM
ProShares Ultra Nasdaq Biotechnology seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.